Cargando…
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
BACKGROUND: Ovarian carcinoma is one of the most aggressive gynecological malignant neoplasms and makes up 25–30% of all cancer cases of the female genital tract. Currently, resistance to traditional chemotherapy is a great challenge for patients with Epithelial ovarian cancer (EOC). Therefore, iden...
Autores principales: | Huang, Hongbiao, Liu, Ni, Liao, Yuning, Liu, Ningning, Cai, Jianyu, Xia, Xiaohong, Guo, Zhiqiang, Li, Yanling, Wen, Qirong, Yin, Qi, Liu, Yan, Wu, Qingxia, Rajakumar, Dhivya, Sheng, Xiujie, Liu, Jinbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471884/ https://www.ncbi.nlm.nih.gov/pubmed/28619062 http://dx.doi.org/10.1186/s13046-017-0547-8 |
Ejemplares similares
-
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016) -
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
por: Zhao, Chong, et al.
Publicado: (2017) -
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
por: Kladnik, Jerneja, et al.
Publicado: (2021) -
Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation
por: Lan, Xiaoying, et al.
Publicado: (2017) -
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017)